Comments
Loading...

Palvella Therapeutics Inc (PVLA) Stock Price, Quote, News & History

PVLANASDAQ
$80.09
-1.45-1.78%
At close: Feb 13, 4:00 PM EST
$80.09
-1.45-1.78%
Pre-Market: 4:00 AM EST

Key Statistics

Open
-
Close
$80.09
Volume / Avg.
0 / 280.73K
Day Range
- - -
52 Wk Range
17.31 - 114.69
Market Cap
$947.98M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
13.9%
Days to Cover
5.63

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-25.47M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
74.17M
Free Cash Flow (TTM)
-25.47M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
48.70M

Analyst Trends and Forecast

2
Oct 25
9
Nov 25
9
Dec 25
3
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$884.42M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
24.51
Earnings Yield % (TTM)
-3.65%
Earnings Yield % (FWD)
-5.27%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.27

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$66.00M
LT Debt Repayment (TTM)
-
Total Cash
$63.57M
Debt to Equity
-
Issuance of Debt (TTM)
$66.00M
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$80.09
Volume / Avg.
0 / 280.73K
Day Range
- - -
52 Wk Range
17.31 - 114.69
Market Cap
$947.98M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
13.9%
Days to Cover
5.63

About

Sector
Health Care
Industry
Biotechnology
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapa...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PVLA
DRUG

FAQ

Q

How do I buy Palvella Therapeutics (PVLA) stock?

A

You can purchase shares of Palvella Therapeutics (NASDAQ:PVLA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Palvella Therapeutics (PVLA) competitors?

Q

What is the forecast, or price target, for Palvella Therapeutics (PVLA) stock?

A

Palvella Therapeutics has a consensus price target of $145.24.

Q

What is the current price for Palvella Therapeutics (PVLA)?

A

The stock price for Palvella Therapeutics (NASDAQ: PVLA) is $80.09 last updated February 17, 2026 at 4:00 PM EST.

Q

Does Palvella Therapeutics (PVLA) pay a dividend?

A

There are no upcoming dividends for Palvella Therapeutics.

Q

When is Palvella Therapeutics (NASDAQ:PVLA) reporting earnings?

A

Palvella Therapeutics does not have any upcoming earnings scheduled.

Q

Is Palvella Therapeutics (PVLA) going to split?

A

There is no upcoming split for Palvella Therapeutics.

Q

What sector and industry does Palvella Therapeutics (PVLA) operate in?

A

Palvella Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.